Effects of Nutritional Supplementation of Leucine and Polyunsaturated Fatty Acids on Muscle Health in the Elderly

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-99
SponsorChang Gung Memorial Hospital

About this trial

Population aging has become a significant global concern, and Taiwan is set to officially enter the "super-aged society" in 2025. As individuals age, various physiological functions gradually decline, including a reduction in muscle mass, which is a key aspect of the aging process.

This interventional study aims to investigate the effects of leucine-rich protein combined with polyunsaturated fatty acid supplementation on middle-aged and elderly individuals (aged 50 and above) who are at high risk for sarcopenia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 50 years

ASMI < 7 kg/m2 in men

ASMI < 5.7 kg/m2 in women

Grip strength < 28 kg in men

Disqualifiers

People who are allergic to supplements

cancer

heart failure

kidney disease

Trial design

Design model

Parallel

Treatments tested in this trial

  • Animal-Based Oil Group

    Dietary supplement

    Participants in animal-based oil group will follow a diet in which the primary fat source is animal-based oil. The diet will supplement for 12 weeks.

  • Plant-Based Oil Group

    Dietary supplement

    Participants in plant-based oil group will follow a diet in which the primary fat source is plant-based oil. The diet will supplement for 12 weeks.

Treatment groups

90 Participants
are divided into 2 treatment groups
Group A: Animal-Based Oil GroupExperimental treatment 1 intervention
Group B: Plant-Based Oil GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

muscle mass

Utilize Bioelectrical Impedance Analysis (BIA) to measure the Appendicular Skeletal Muscle Mass Index Level (ASMI) (kg/m\^2)

Time frame
baseline, 12 weeks
2

muscle function

utilize handgrip dynamometer to measure the hand grip strength (kg).

Time frame
baseline, 12 weeks
3

physical function

To assess the participant's walking speed over a 4-meter distance.

Time frame
baseline, 12 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chang Gung Memorial Hospital

Lead sponsor

Chang Gung University

Collaborator